{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:26:17Z","timestamp":1785547577041,"version":"3.56.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Thyroid hormone resistance (THR) is a rare genetic syndrome characterized by reduced sensitivity to thyroid hormones. Patients may be asymptomatic, although clinical manifestations depend on the THR subtype. This entity commonly has abnormal thyroid function tests and can be confirmed by molecular analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The present study describes a 55 year-old female diagnosed with surgically resected papillary thyroid carcinoma. During the endocrinology consults, elevated thyroid hormone levels were detected without an adequate TSH response, and THR was suspected. Moreover, Parkinson\u2019s disease was diagnosed, and treatment with levodopa\/carbidopa was initiated. Following this regimen, her TSH and total T3 levels were subsequently normalized, which suggests a potential effect of this agent on the normalization of these hormone levels in the blood. In this case, the role of levodopa was crucial to regulate the TSH concentration which was required to carry out the resection of a tumoral remnant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The influence of dopamine in the endocrine system, specifically in the thyroid gland, is beneficial in conditions such as THR where abnormal TSH levels can be lowered, helping to balance the thyroid and hormones function.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1536372","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T05:23:43Z","timestamp":1742275423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Levodopa induces thyroid function regulation in a patient with thyroid hormone resistance and Parkinson\u2019s disease: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Gabriela","family":"Rozo-Paz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Maria","family":"Ruiz-Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 David","family":"Su\u00e1rez-Mera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Monsalve Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kattah Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.endonu.2011.02.001","article-title":"S\u00edndromes de resistencia a las hormonas tiroideas","volume":"58","author":"Bernal","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.656551","article-title":"Resistance to thyroid hormone beta: A focused review","volume":"12","author":"Pappa","year":"2021","journal-title":"Front Endocrinol"},{"key":"B3","article-title":"Physiology, thyroid hormone","volume-title":"StatPearls","author":"Shahid","year":"2024"},{"key":"B4","article-title":"Resistance to thyroid hormone","volume-title":"Endocrine Development","author":"Onigata","year":"2014"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111679","DOI":"10.1016\/j.mce.2022.111679","article-title":"Thyroid hormone resistance: Mechanisms and therapeutic development","volume":"553","author":"Yao","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49913","article-title":"Thyroid hormone resistance syndrome: from molecular mechanisms to its potential contribution to hypertension","volume":"15","author":"Prakash","year":"2023","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1968.28.2.0093","article-title":"Anatomical variations in the pituitary gland and adjacent structures in 225 human autopsy cases","volume":"28","author":"Bergland","year":"1968","journal-title":"J Neurosurg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.925378","article-title":"A multicenter cohort study in patients with primary empty sella: hormonal and neuroradiological features over a long follow-up","volume":"13","author":"Carosi","year":"2022","journal-title":"Front Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-18-0104","article-title":"Resistance to thyroid hormone-beta co-existing with partially empty sella in a Jordanian male","volume":"2018","author":"Al Mohareb","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0288","article-title":"Primary empty Sella","volume":"90","author":"De Marinis","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: Pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.12.002","article-title":"Pharmacologic treatment of motor symptoms associated with Parkinson disease","volume":"38","author":"Poewe","year":"2020","journal-title":"Neurol Clin"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200212","article-title":"Inhibition of L -{18 F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography","volume":"20","author":"Leenders","year":"1986","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00002826-198403000-00002","article-title":"Pharmacokinetics of levodopa","volume":"7","author":"Nutl","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-007-9442-6","article-title":"The role of 3-O-methyldopa in the side effects of l-dopa","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180505","article-title":"The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: The mechanism of action in the treatment of parkinsonism","volume":"18","author":"Nutt","year":"1985","journal-title":"Ann Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2012.210","article-title":"The vascular neural network\u2014a new paradigm in stroke pathophysiology","volume":"8","author":"Zhang","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2014.00242","article-title":"Presynaptic mechanisms of l-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications","volume":"5","author":"Cenci","year":"2014","journal-title":"Front Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-020-01314-5","article-title":"Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors","volume":"44","author":"Mohammadi","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(86)90226-X","article-title":"Divergent dopaminergic regulation of TSH, free \u03b1-subunit, and TSH-\u03b2 in pituitary cell culture","volume":"35","author":"Greenspan","year":"1986","journal-title":"Metabolism"},{"key":"B22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/archneur.1981.00510120059009","article-title":"Effect of levodopa on thyroid function and prolactin release: A study in patients with Parkinson\u2019s disease","volume":"38","author":"Lavin","year":"1981","journal-title":"Arch Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.29.7.1073","article-title":"Sinemet\u00ae and thyroid function in Parkinson disease","volume":"29","author":"Wingert","year":"1979","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-3-488","article-title":"Effects of prolonged dopamine infusion on anterior pituitary function in normal males*","volume":"51","author":"Kaptein","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000182105","article-title":"Dopaminergic regulation of gonadotropin and thyrotropin hormone secretion is altered with age","volume":"36","author":"Greenspan","year":"1991","journal-title":"Horm Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-3-480","article-title":"Dopamine affects basal and augmented pituitary hormone secretion*","volume":"47","author":"Leebaw","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000179437","article-title":"Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients","volume":"15","author":"Rabey","year":"1981","journal-title":"Horm Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1353-8020(99)00010-3","article-title":"Thyroid function and autoimmunity in Parkinson\u2019s disease: a study of 101 patients","volume":"5","author":"Bonuccelli","year":"1999","journal-title":"Parkinsonism Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1430303","article-title":"Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats","volume":"143","author":"Cabanillas","year":"1994","journal-title":"J Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-4-731","article-title":"Use of bromocriptine in a patient with generalized resistance to thyroid hormone*","volume":"58","author":"Bajorunas","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(82)90242-6","article-title":"Familial thyroid hormone resistance","volume":"31","author":"Cooper","year":"1982","journal-title":"Metabolism"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1536372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T05:23:45Z","timestamp":1742275425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1536372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":31,"alternative-id":["10.3389\/fendo.2025.1536372"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1536372","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1536372"}}